10 AI News You Should Not Miss

2. Alphabet Inc. (NASDAQ:GOOGL)

Number of Hedge Fund Holders: 202

Alphabet Inc. (NASDAQ:GOOGL) offers AI-powered solutions across multiple platforms, enhancing cloud services, business tools, and consumer products, with a strong emphasis on advancing AI research.

Isomorphic Labs, a spin-off of Google DeepMind and a subsidiary of Alphabet (NASDAQ:GOOGL) has planned to start clinical trials for AI-designed drugs by the end of this year, according to CEO Demis Hassabis. Bloomberg reported on January 21 that the company aims to reduce the drug discovery timeline from decades to weeks, using advancements like AlphaFold, which models complex molecular structures such as proteins, DNA, and RNA. Hassabisa also highlighted partnerships with pharmaceutical firms and while he was optimistic about AI’s potential in drug development, he noted that achieving artificial general intelligence could take another five years and require significant breakthroughs.